室内生物气溶和喘:概述,影响和缓解策略
Karen C Dannemiller1, Laura A Conrad2, Sarah R Haines3
1Civil, Environmental, and Geodetic Engineering, College of Engineering, The Ohio State University, Columbus, Ohio; Environmental Health Sciences, College of Public Health, The Ohio State University, Columbus, Ohio; Sustainability Institute, College of Engineering, The Ohio State University, Columbus, Ohio.
The Journal of allergy and clinical immunology
|November 29, 2024
概括
生物气溶,空气中的生物颗粒,可以引发喘. 有效的管理包括识别来源和实施控制策略,如减少来源和空气过,以减轻暴露风险.
科学领域:
- 环境健康 环境健康
- 传染病流行病学 传染病流行病学
- 过敏和免疫学 过敏和免疫学
背景情况:
- 来自植物,动物,真菌,细菌和病毒的生物气溶,代表了与喘有关的重大环境暴露.
- 不同的生物气溶通过不同的途径对喘产生影响,个体易感性各不相同,影响缓解的有效性.
- 目前的喘管理指南包括减少暴露的策略,但建筑通风标准可能不会特别保护喘患者.
研究的目的:
- 审查与喘不良结果相关的生物气溶现有知识.
- 讨论各种生物气溶触发物的有效缓解策略.
主要方法:
- 文献综述总结了关于生物气溶和喘的研究.
- 对不同类型的生物气溶 (过敏原,真菌,细菌,病毒) 的分析及其临床相关性.
- 评估减少和减轻暴露的技术.
主要成果:
- 来自各种生物来源的生物气溶在临床上与喘有关.
- 不同的生物气溶通过独特的机制影响喘,需要量身定制的敏感性考虑.
- 源控制 (例如,减少复杂化,综合害虫管理,湿度控制) 和增强空气过是关键的缓解策略.
结论:
- 了解生物气溶与喘之间的联系对于有效管理至关重要.
- 源控制和空气过是减少喘患者暴露于生物气溶的主要方法.
- 对特定的生物气溶通路和个体敏感性的进一步研究可以改进缓解策略.
相关概念视频
Asthma-I: Introduction
2.6K
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
2.6K
Drugs Used in Lower Respiratory Disorders: Overview
352
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
352
Asthma: Pathogenesis and Management
351
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
351
Asthma-IV: Diagnostic and Management
2.5K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.5K
Asthma-II: Pathophysiology and Classification
2.6K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
2.6K
Asthma-III: Symptoms and Complications
2.5K
Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
Classification of Asthma
2.5K


